Carolin Lerchenmüller

Carolin Lerchenmüller

Auto-generated profile, based on publicly available information

Carolin Lerchenmüller

Chair for Gender Medicine, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
Ana VujicAna Vujic
Ana Vujic
CLCarolin Lerchenmüller
Carolin Lerchenmüller
TWTing-Di Wu
Ting-Di Wu
CGChristelle Guillermier
Christelle Guillermier
CRCharles P. Rabolli
Charles P. Rabolli
ARAnthony Rosenzweig
Anthony Rosenzweig
Loss of cardiomyocytes is a major cause of heart failure, and while the adult heart has a limited capacity for cardiomyogenesis, little is known about what regulates this ability or whether it can be effectively harnessed. Here we show that 8 weeks of running exercise increase birth of new cardiomyocytes in adult mice (~4.6-fold). New cardiomyocytes are identified based on incorporation of 15N-thymidine by multi-isotope imaging mass spectrometry (MIMS) and on being mononucleate/diploid. Furthermore, we demonstrate that exercise after myocardial infarction induces a robust cardiomyogenic response in an extended border zone of the infarcted area. Inhibition of miR-222, a microRNA increased by exercise in both animal models and humans, completely blocks the cardiomyogenic exercise response. These findings demonstrate that cardiomyogenesis can be activated by exercise in the normal and injured adult mouse heart and suggest that stimulation of endogenous cardiomyocyte generation could contribute to the benefits of exercise.

16 June 2016 in JCI Insight
Verified
Journal Article
Open access
PDF file
VBVassilios J. Bezzerides
Vassilios J. Bezzerides
CPColin Platt
Colin Platt
CLCarolin Lerchenmüller
Carolin Lerchenmüller
KPKaavya Paruchuri
Kaavya Paruchuri
NONul Loren Oh
Nul Loren Oh
ARAnthony Rosenzweig
Anthony Rosenzweig
The mechanisms by which exercise mediates its multiple cardiac benefits are only partly understood. Prior comprehensive analyses of the cardiac transcriptional components and microRNAs dynamically regulated by exercise suggest that the CBP/p300-interacting protein CITED4 is a downstream effector in both networks. While CITED4 has documented functional consequences in neonatal cardiomyocytes in vitro, nothing is known about its effects in the adult heart. To investigate the impact of cardiac CITED4 expression in adult animals, we generated transgenic mice with regulated, cardiomyocyte-specific CITED4 expression. Cardiac CITED4 expression in adult mice was sufficient to induce an increase in heart weight and cardiomyocyte size with normal systolic function, similar to the effects of endurance exercise training. After ischemia-reperfusion, CITED4 expression did not change initial infarct size but mediated substantial functional recovery while reducing ventricular dilation and fibrosis. Forced cardiac expression of CITED4 also induced robust activation of the mTORC1 pathway after ischemic injury. Moreover, pharmacological inhibition of mTORC1 abrogated CITED4’s effects in vitro and in vivo. Together, these data establish CITED4 as a regulator of mTOR signaling that is sufficient to induce physiologic hypertrophy at baseline and mitigate adverse ventricular remodeling after ischemic injury.

22 May 2020 in Aging Cell
Verified
Journal Article
Open access
PDF file
JRJason D. Roh
Jason D. Roh
NHNicholas Houstis
Nicholas Houstis
AYAndy Yu
Andy Yu
BCBliss Chang
Bliss Chang
AYAshish Yeri
Ashish Yeri
ARAnthony Rosenzweig
Anthony Rosenzweig
Heart failure with preserved ejection fraction (HFpEF) is the most common type of HF in older adults. Although no pharmacological therapy has yet improved survival in HFpEF, exercise training (ExT) has emerged as the most effective intervention to improving functional outcomes in this age‐related disease. The molecular mechanisms by which ExT induces its beneficial effects in HFpEF, however, remain largely unknown. Given the strong association between aging and HFpEF, we hypothesized that ExT might reverse cardiac aging phenotypes that contribute to HFpEF pathophysiology and additionally provide a platform for novel mechanistic and therapeutic discovery. Here, we show that aged (24–30 months) C57BL/6 male mice recapitulate many of the hallmark features of HFpEF, including preserved left ventricular ejection fraction, subclinical systolic dysfunction, diastolic dysfunction, impaired cardiac reserves, exercise intolerance, and pathologic cardiac hypertrophy. Similar to older humans, ExT in old mice improved exercise capacity, diastolic function, and contractile reserves, while reducing pulmonary congestion. Interestingly, RNAseq of explanted hearts showed that ExT did not significantly modulate biological pathways targeted by conventional HF medications. However, it reversed multiple age‐related pathways, including the global downregulation of cell cycle pathways seen in aged hearts, which was associated with increased capillary density, but no effects on cardiac mass or fibrosis. Taken together, these data demonstrate that the aged C57BL/6 male mouse is a valuable model for studying the role of aging biology in HFpEF pathophysiology, and provide a molecular framework for how ExT potentially reverses cardiac aging phenotypes in HFpEF.

5 April 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
CLCarolin Lerchenmüller
Carolin Lerchenmüller
LSLeo Schmallenbach
Leo Schmallenbach
AJAnupam B Jena
Anupam B Jena
MLMarc J Lerchenmueller
Marc J Lerchenmueller
Objective Concerns have been raised that the COVID-19 pandemic has shifted research productivity to the disadvantage of women in academia, particularly in early career stages. In this study, we aimed to assess the pandemic’s effect on women’s COVID-19-related publishing over the first year of the pandemic. Methods and results We compared the gender distribution of first authorships for 42 898 publications on COVID-19 from 1 February 2020 to 31 January 2021 to 483 232 publications appearing in the same journals during the same period the year prior. We found that the gender gap—the percentage of articles on which men versus women were first authors—widened by 14 percentage points during the COVID-19 pandemic, despite many pertinent research fields showing near equal proportions of men and women first authors publishing in the same fields before the pandemic. Longitudinal analyses revealed that the significant initial expansions of the gender gap began to trend backwards to expected values over time in many fields. As women may have been differentially affected depending on their geography, we also assessed the gender distribution of first authorships grouped by countries and geographical areas. While we observed a significant reduction of the shares of women first authors in almost all countries, longitudinal analyses confirmed a resolving trend over time. Conclusion The reduction in women’s COVID-19-related research output appears particularly concerning as many disciplines informing the response to the pandemic had near equal gender shares of first authorship in the year prior to the pandemic. The acute productivity drain with the onset of the pandemic magnifies deep-rooted obstacles on the way to gender equity in scientific contribution.

1 August 2011 in JACC
Verified
Journal Article
Closed access
HBHenriette Brinks
Henriette Brinks
DRDavid Rohde
David Rohde
MVMirko Voelkers
Mirko Voelkers
GQGang Qiu
Gang Qiu
SPSven T. Pleger
Sven T. Pleger
PMPatrick Most
Patrick Most

20 February 2018 in Circulation
Verified
Journal Article
Closed access
PDF file
CLCarolin Lerchenmüller
Carolin Lerchenmüller
MLMarc J. Lerchenmueller
Marc J. Lerchenmueller
OSOlav Sorenson
Olav Sorenson